Nurses should follow their facilitys protocols regarding the safe administration of aerosol therapy
Here is the 2026-specific development that changes the calculus: the FDA has stated that the national shortage designations for semaglutide and tirzepatide injection products have been resolved
In a Phase 2 trial, the highest doses produced an average ~24% body-weight reduction at 11 months (American Diabetes Association)
Marketed as Ozempic and Wegovy, semaglutide has proven highly effective in lowering blood sugar levels in type 2 diabetes patients and promoting significant weight loss in individuals with obesity
Side effects, diet plans, dosage guides, and the latest research written by medical reviewers and backed by clinical trials
GLP -1 receptors are activated, and the brain sends the message that it is fuller and decreases hunger